Hunan Warrant Pharmaceutical (SHA:688799) received approval from China's drug administrator for the listing application of its active pharmaceutical ingredient bismuth potassium citrate.
Bismuth potassium citrate is a gastric mucosal protective agent, commonly used to treat chronic gastritis and alleviate acid-related stomach pain, according to a Monday filing with the Shanghai bourse.
Shares of the pharmaceutical company closed 4% higher Monday.